Clinical trials: Skin Toxicity
Rheumatoid Arthritis (RA)
Effect of Silymarin in Rheumatoid Arthritis Patients Treated With Methotrexate
The goal of this clinical trial is to evaluate the anti-rheumatic activity and the role of silymarin in attenuating methotrexate toxicity in patients with rheumatoid arthritis.
- Trial name
- NCT06724952
- Testing
- MTX S.C or IM and Silymarin 140 mg tab, MTX S.C or IM
- Where
- Egypt
- Volunteers
- 44 people
- Sponsor
- Tanta University
Hand and Foot Skin Reaction, Colorectal Cancer Stage IV
Study on the Prevention of Dermal Toxicity Caused by Regorafenib by Traditional Chinese Medicine TDX105
this is an preventive study to evaluate the preventive effect of traditional chinese medicine TDX105 on Regorafenib induced Dermatologic Toxicities
- Trial name
- NCT05289726
- Testing
- Traditional chinese medicine TDX105
- Where
- China
- Volunteers
- 152 people
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Cardiac Toxicity, Inflammatory Breast Cancer
Combination Chemotherapy, Surgery, and Radiation Therapy With or Without Dexrazoxane and Trastuzumab in Treating Women With Stage III or Stage IV Breast Cancer
Randomized phase III trial to compare the effectiveness of combination chemotherapy, surgery, and radiation therapy with or without dexrazoxane and trastuzumab in treating women who have stage IIIA, stage IIIB or stage IV breast…
- Conditions
- Cardiac Toxicity, Inflammatory Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer
- Trial name
- NCT00016276
- Testing
- dexrazoxane hydrochloride, doxorubicin hydrochloride, cyclophosphamide
- Where
- United States
- Volunteers
- 396 people
- Sponsor
- National Cancer Institute (NCI)
Breast Cancer, Prostate Cancer
Evaluation of an Apoptotic Test for Predicting Late Toxicities After Radiotherapy in Breast and Prostate Cancer Patients
The primary objective of this study is to evaluate the prediction of late toxicity by the radiation induced CD8 T-lymphocyte apoptosis
- Trial name
- NCT00893035
- Where
- France
- Volunteers
- 885 people
- Sponsor
- Institut du Cancer de Montpellier - Val d'Aurelle
Colitis, Hepatitis
PHOENIX-ECP- Extracorporeal Photopheresis for Immune-related Colitis and/or Hepatitis in Advanced Melanoma With Inadequate Response to Steroid Exposure
Extracorporeal photopheresis (ECP) is an immunomodulatory therapy in which the photoactivating agent methoxsalen (also known as UVADEX) is used in combination with ultraviolet A (UVA) light.
- Conditions
- Colitis, Hepatitis, Melanoma (Skin Cancer)
- Trial name
- PHOENIX-ECP (NCT07619898)
- Testing
- methoxsalen, Extracorporeal photopheresis (ECP), Vedolizumab
- Volunteers
- 112 people
- Sponsor
- Therakos LLC
Breast Cancer, Nail Toxicity
Taxane Chemotherapy and Nail Toxicity in Women With Breast Cancer; Stage Two: Evaluation of Interventions
The study compares three strategies to prevent/minimise nail problems occuring in women, with breast cancer, undergoing Taxane chemotherapy.
- Trial name
- NCT02583204
- Testing
- Onicolife nail drops, Nail polish
- Where
- United Kingdom
- Volunteers
- 105 people
- Sponsor
- NHS Greater Glasgow and Clyde
Breast Cancer, Radiation Toxicity
Atrial Fibrillation and Other Cardiac Arrhythmias and Diseases After Radiotherapy for Breast Cancer : Watch Your HeaRT
The goal of this interventional study is to evaluate the risk of atrial fibrillation (AF) and other cardiac arrhythmias and diseases in breast cancer patients treated with radiation therapy (RT).
- Conditions
- Breast Cancer, Radiation Toxicity, Atrial Fibrillation, Cardiac Arrhythmia
- Trial name
- WATCH (NCT06073509)
- Testing
- Screening for atrial fibrillation and other cardiac arrhythmias and diseases
- Where
- France
- Volunteers
- 200 people
- Sponsor
- Sophie JACOB
Melanoma, Neoplasm Metastasis
Lymphocyte Re-infusion During Immune Suppression to Treat Metastatic Melanoma
This experiment will test the safety and effectiveness of a treatment for melanoma in which certain lymphocytes (a type of white blood cell) are taken from the patient, grown in the laboratory, and returned after the patient's…
- Trial name
- NCT00001832
- Testing
- gp100:209-217 (210M), Montanide ISA-51, IL-2
- Where
- United States
- Volunteers
- 170 people, healthy volunteers welcome
- Sponsor
- National Cancer Institute (NCI)
Rash Acneiform
DWP708 for Treating Epidermal Growth Factor Receptor Inhibitor Related Skin Toxicities
A Multi-center, Randomized, Double-blind, Placebo-controlled, Therapeutic Exploratory, Phase II Clinical Trial for the Efficacy Investigation and Safety Evaluation of DWP708 for Treating Rash Acneiform
- Trial name
- NCT05378360
- Testing
- DWP708
- Where
- South Korea
- Volunteers
- 96 people
- Sponsor
- Daewoong Pharmaceutical Co. LTD.
Breast Carcinoma
Trial Comparing Prone and Supine Intensity-modulated Radiotherapy (IMRT) After Breast-conserving Surgery in Patients With Large Breast Volume at High Risk for Skin Toxicity and Fibrosis
84 patients with a cup size C or more will be randomized to receive intensity-modulated radiotherapy in supine or prone position.
- Trial name
- NCT00887523
- Testing
- radiation in prone position, radiation in supine position
- Where
- Belgium
- Volunteers
- 100 people
- Sponsor
- University Hospital, Ghent
Breast Cancer
Predicting Response and Toxicity in Patients Receiving Lonafarnib for Breast Cancer
This is a tumor and serum collection study for patients with advanced breast cancer receiving treatment with lonafarnib.
- Trial name
- NCT01232881
- Testing
- Tumor Sample, Serum Sample
- Where
- United States
- Volunteers
- 27 people
- Sponsor
- Hoosier Cancer Research Network
Breast Cancer, Early-stage Breast Cancer
Ultra Hypo-fractionated Adjuvant Whole Breast Radiation Therapy With Simultaneous Integrated Boost for Early-Stage Breast Cancer (H-ASSIST)
This study evaluates the rates of radiation-specific toxicity, quality of life, and oncologic outcomes for early-stage breast cancer and ductal carcinoma in situ treated with 5-fraction whole breast irradiation (WBI) with a…
- Conditions
- Breast Cancer, Early-stage Breast Cancer, Ductal Carcinoma in Situ, DCIS
- Trial name
- H-ASSIST (NCT06902311)
- Testing
- Breast Radiotherapy
- Where
- United States
- Volunteers
- 90 people
- Sponsor
- UNC Lineberger Comprehensive Cancer Center
Breast Cancer, Cardiac Toxicity
Doxorubicin and Cyclophosphamide Followed By Trastuzumab, Paclitaxel, and Lapatinib in Treating Patients With Early-Stage HER2-Positive Breast Cancer That Has Been Removed By Surgery
RATIONALE: Drugs used in chemotherapy, such as doxorubicin, cyclophosphamide, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing.
- Trial name
- NCT00436566
- Testing
- trastuzumab, cyclophosphamide, doxorubicin hydrochloride
- Where
- United States
- Volunteers
- 122 people
- Sponsor
- Mayo Clinic
Herpes Simplex
Acyclovir in Preventing Herpes Simplex Virus Infection in Patients With Neutropenia
RATIONALE: Acyclovir may be effective in preventing herpes simplex virus infection in patients with neutropenia. PURPOSE: This randomized phase III trial is studying the side effects of acyclovir and is comparing two doses of…
- Trial name
- NCT00855309
- Testing
- acyclovir sodium
- Where
- United States
- Volunteers
- 112 people
- Sponsor
- Wake Forest University Health Sciences
Acne Vulgaris
Toxicity and Efficacy Evaluation of Topical Minoxidil in Acne Vulgaris
Patients with acne vulgaris (AV) appeared to be a chronic inflammation with a wide range in teenagers and adult. The protocol design is as follows.
- Trial name
- NCT06108193
- Testing
- topical minoxidil in Acne Vulgaris
- Where
- Taiwan
- Volunteers
- 26 people
- Sponsor
- Chang Gung Memorial Hospital
Breast Cancer
Proton vs Photon IMRT Toxicity in Breast Cancer
This study aims to compare the differences in acute and long-term toxicities between intensity-modulated proton therapy (IMPT) and intensity-modulated photon radiotherapy (IMRT/VMAT) in postoperative breast cancer patients, with…
- Trial name
- PPTOX-BC (NCT07537712)
- Testing
- Intensity-modulated photon radiotherapy (IMRT/VMAT), Intensity-modulated proton therapy (IMPT)
- Where
- China
- Volunteers
- 750 people
- Sponsor
- Ruijin Hospital
Breast Adenocarcinoma, Radiation Dermatitis
Cicaderma Efficacy vs Standard Care of Sites in Preventing Radiodermatitis in Non-metastatic Breast Cancer Patients
Phase III, prospective, interventional, multicentric, comparative, randomized, open study with 2 parallel arms, evaluating the efficacy of Cicaderma ointment vs standard management of each site in preventing the onset of grade >…
- Conditions
- Breast Adenocarcinoma, Radiation Dermatitis, Radiation Toxicity
- Trial name
- CICA-RT (NCT04300829)
- Testing
- cicaderma + simple hygiene rules, Simple hygiene rules and a maximum of one topical treatment
- Where
- 3 sites in France
- Volunteers
- 248 people
- Sponsor
- Centre Leon Berard
Cancer
Prevention of Capecitabine Induced Hand and Foot Syndrome
Capecitabine is a common anti cancer drug. One of the most common side effects is a syndrome called hand and foot syndrome which comprises of hands and feet redness, swelling, dryness and painful sores.
- Trial name
- NCT01291628
- Testing
- socks containing copper-oxide fibers
- Where
- Israel
- Volunteers
- 10 people
- Sponsor
- Rabin Medical Center
Glioblastoma, Recurrent Glioblastoma
Clindamycin and Triamcinolone in People With Glioblastoma to Prevent Skin-Related Side Effects of Tumor Treating Fields
The participants are being treated with Tumor Treating Fields (TTFields) for malignant glioma, and this type of treatment may cause skin-related side effects.
- Conditions
- Glioblastoma, Recurrent Glioblastoma, Skin Toxicity
- Trial name
- NCT04469075
- Testing
- Clindamycin Phosphate, Triamcinolone Acetonide
- Where
- 8 sites in United States
- Volunteers
- 48 people
- Sponsor
- Memorial Sloan Kettering Cancer Center
Radiodermatitis, Radiation Toxicity
A Novel Skin Barrier Protectant for Acute Radiodermatitis
Acute radiodermatitis (ARD) is a distressing and painful skin reaction that occurs in 95% of the patients undergoing radiotherapy (RT).
- Conditions
- Radiodermatitis, Radiation Toxicity, Radiation Dermatitis, Skin Diseases
- Trial name
- CASP-ORL (NCT04593914)
- Testing
- Cavilon Advanced Skin Protectant
- Where
- 2 sites in Belgium
- Sponsor
- Jessa Hospital